Bisht Akanksha, Patidar Gopal Kumar, Arora Satyam, Marwaha Neelam
Haemovigilance Programme of India (HvPI), National Institute of Biologicals, Ministry of Health and Family Welfare, Government of India, Noida, Uttar Pradesh, India.
Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.
Vox Sang. 2024 Dec;119(12):1278-1284. doi: 10.1111/vox.13741. Epub 2024 Oct 6.
Implementation of national haemovigilance programmes has significantly improved donor and recipient safety. Recently, India completed a decade of successful implementation of its national haemovigilance programmes. The national programme is still enrolling more blood centres. This study aimed to highlight the strengths and weaknesses of Haemovigilance Programme of India (HvPI), thereby providing valuable insights for future initiatives.
The National Coordinating Centre (NCC) conducted a multi-centre, cross-sectional questionnaire-based survey among the reporting blood centres (January to April 2022). The survey consisted of three sections with a total of 27 questions focusing on the demographics of the participant blood centre as well as the impact on the recipient and donor haemovigilance. The survey was sent to 733 blood centres regularly reporting to the donor and recipient HvPI through Donor and Hemovigil Software.
Total 296 responses were received (response rate of 40.4%) with maximum participation of private non-teaching hospital-based blood centres (33.8%). After their involvement in recipient HvPI, 85.7% of the respondents reported changes in their blood centre's work procedures, with the maximum improvement seen in the documentation of transfusion reactions (92.7%). Out of the 278 respondents who participated in donor HvPI, 89.9% (250) found that their blood centre's policies or work process changed as a result of their involvement in the programme.
In conclusion, our haemovigilance programme facilitates national collaboration for learning and sharing experiences, leading to improved policies and practices in reducing adverse reactions for both recipients and donors.
国家血液警戒计划的实施显著提高了献血者和受血者的安全性。最近,印度成功实施国家血液警戒计划已满十年。国家计划仍在纳入更多的血液中心。本研究旨在突出印度血液警戒计划(HvPI)的优势与不足,从而为未来的举措提供有价值的见解。
国家协调中心(NCC)于2022年1月至4月在报告血液中心开展了一项基于问卷调查的多中心横断面调查。该调查由三个部分组成,共27个问题,重点关注参与调查的血液中心的人口统计学信息以及对受血者和献血者血液警戒的影响。调查问卷发送给了733个通过献血者和血液警戒软件定期向献血者和受血者HvPI报告的血液中心。
共收到296份回复(回复率为40.4%),其中私立非教学医院的血液中心参与度最高(33.8%)。参与受血者HvPI后,85.7%的受访者表示其血液中心的工作程序发生了变化,其中输血反应记录方面的改善最为明显(92.7%)。在参与献血者HvPI的278名受访者中,89.9%(250人)发现其血液中心的政策或工作流程因参与该计划而发生了变化。
总之,我们的血液警戒计划促进了全国范围内的学习与经验分享合作,从而改进了政策和做法,减少了受血者和献血者的不良反应。